Basal Cell Carcinoma (BCC)

Dermatology / Oncology

Overview

Definition

The most common type of skin cancer, arising from the basal cells of the lower epidermis.

Epidemiology

Extremely common. Accounts for ~80% of all non-melanoma skin cancers. Very low metastatic potential.

Etiology & Risk Factors

  • Cumulative, chronic UV light (sun) exposure.
  • Associated with PTCH1 gene mutations.

Clinical Symptoms

  • Pearly, translucent papule or nodule with rolled borders
  • Telangiectasias (visible blood vessels) on the surface
  • Central ulceration ('rodent ulcer')
  • Often found on sun-exposed areas (face, nose, neck)

Clinical Approach

Diagnosis

  • Shave biopsy or Punch biopsy: Shows basophilic palisading cells dropping into the dermis

Management

  • Surgical Excision: Standard treatment for most lesions
  • Mohs Micrographic Surgery: Preferred for high-risk areas (face, hands, genitals) to spare healthy tissue while ensuring clear margins
  • Topical therapies (Imiquimod, 5-FU) for superficial BCC

Complications

  • Local tissue destruction and disfigurement (rarely metastasizes, but can aggressively destroy local cartilage/bone if neglected)